Feeling unwell or injured? Make sure you choose the right service.
The Department of Oncology treats cancers of solid organs. We offer a highly integrated approach to the management of both common and rare cancers.
Staff profile block: 

Dr Hugo Ford

Director of Cancer Services
Dr Hugo Ford

"My special interest is in gastrointestinal cancer".

We provide a service to more than 4,000 new patients each year, from East Anglia and beyond. We are a very busy centre: in 2010, 2,020 individual patients were commenced on chemotherapy and over 11,000 treatments were administered.

Our chemotherapy service functions both as a local service for Cambridgeshire and a specialist service for the Anglia Cancer Network (ACN) and beyond. We receive referrals from across our region as well as nationally.

We treat en extensive range of cancers, including:

  • Biliary tract
  • Bladder
  • Bowel
  • Brain
  • Breast
  • Gynaecological
  • Haematological
  • Head and Neck
  • Kidney
  • Lung
  • Neuroendocrine
  • Oesophagus and stomach
  • Paediatric
  • Pancreas
  • Primary liver
  • Prostate
  • Sarcoma
  • Skin

We have expertise in the use of all of the common types of treatment and most of the more specialist ones. They include: cytotoxic chemotherapy, immunotherapy, molecular targeted agents, monoclonal antibodies, hormone therapy. For more information on the treatments we offer, please see Your treatment > Chemotherapy

We have very close links with the University of Cambridge Department of Oncology and Haematology. Many of our staff work for both the hospital and the university. This ensures that the high-quality cancer care we offer, is underpinned by excellent research.

We offer a large number of ground breaking new treatments within clinical trials. Addenbrooke’s is the hub of the West Anglia Cancer Research Networks and accounts for over two thirds of its activity. In 1022, 1,649 patients treated in our Cancer Centre took part in 169 different clinical trials. For more information, please see our section on Research.

In March 2012, we launched two new and exciting developments to our service: